Venetoclax was changed how we treat CLL, but it doesn't work for everyone and it doesn't always continue to work. In the first part of my interview with Dr. Kipps at ASH 2018, he discusses resistance and how to possibly avoid it: cllsociety.org/2019/04/ash-....
Dr. Kipps is the master of analogy- this time whack-a-mole.
I must admit that I am missing the commentary and context that Chris Dwyer would have brought to this post about this topic.
This Saturday I will be in Minneapolis for the CLL Society/Mayo Educational Forum, so if you are attending please say hello. Mayo has a ridiculously strong faculty lined up.
Stay strong, we are all in this together, through all the good and the bad.
Brian Koffman -CLLSociety.org